Veracyte PE Ratio 2012-2025 | VCYT
Current and historical p/e ratio for Veracyte (VCYT) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Veracyte PE ratio as of May 23, 2025 is 30.11.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Veracyte PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-05-23 | 27.16 | 66.24 | |
| 2025-03-31 | 29.65 | $0.41 | 72.32 |
| 2024-12-31 | 39.60 | $0.30 | 132.00 |
| 2024-09-30 | 34.04 | $-0.15 | 0.00 |
| 2024-06-30 | 21.67 | $-0.75 | 0.00 |
| 2024-03-31 | 22.16 | $-0.94 | 0.00 |
| 2023-12-31 | 27.51 | $-1.03 | 0.00 |
| 2023-09-30 | 22.33 | $-0.69 | 0.00 |
| 2023-06-30 | 25.47 | $-0.40 | 0.00 |
| 2023-03-31 | 22.30 | $-0.41 | 0.00 |
| 2022-12-31 | 23.73 | $-0.50 | 0.00 |
| 2022-09-30 | 16.60 | $-0.60 | 0.00 |
| 2022-06-30 | 19.90 | $-0.68 | 0.00 |
| 2022-03-31 | 27.57 | $-0.68 | 0.00 |
| 2021-12-31 | 41.20 | $-1.14 | 0.00 |
| 2021-09-30 | 46.45 | $-1.13 | 0.00 |
| 2021-06-30 | 39.98 | $-1.01 | 0.00 |
| 2021-03-31 | 53.75 | $-1.10 | 0.00 |
| 2020-12-31 | 48.94 | $-0.68 | 0.00 |
| 2020-09-30 | 32.49 | $-0.69 | 0.00 |
| 2020-06-30 | 25.90 | $-0.63 | 0.00 |
| 2020-03-31 | 24.31 | $-0.46 | 0.00 |
| 2019-12-31 | 27.92 | $-0.27 | 0.00 |
| 2019-09-30 | 24.00 | $-0.20 | 0.00 |
| 2019-06-30 | 28.51 | $-0.30 | 0.00 |
| 2019-03-31 | 25.02 | $-0.43 | 0.00 |
| 2018-12-31 | 12.58 | $-0.65 | 0.00 |
| 2018-09-30 | 9.55 | $-0.81 | 0.00 |
| 2018-06-30 | 9.34 | $-0.90 | 0.00 |
| 2018-03-31 | 5.56 | $-0.94 | 0.00 |
| 2017-12-31 | 6.53 | $-0.91 | 0.00 |
| 2017-09-30 | 8.77 | $-0.81 | 0.00 |
| 2017-06-30 | 8.33 | $-0.80 | 0.00 |
| 2017-03-31 | 9.18 | $-0.98 | 0.00 |
| 2016-12-31 | 7.74 | $-1.10 | 0.00 |
| 2016-09-30 | 7.61 | $-1.25 | 0.00 |
| 2016-06-30 | 5.03 | $-1.37 | 0.00 |
| 2016-03-31 | 5.40 | $-1.32 | 0.00 |
| 2015-12-31 | 7.20 | $-1.30 | 0.00 |
| 2015-09-30 | 4.69 | $-1.37 | 0.00 |
| 2015-06-30 | 11.14 | $-1.42 | 0.00 |
| 2015-03-31 | 7.28 | $-1.38 | 0.00 |
| 2014-12-31 | 9.66 | $-1.36 | 0.00 |
| 2014-09-30 | 9.75 | $-1.42 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.146B | $0.446B |
| Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $194.503B | 85.19 |
| Thermo Fisher Scientific (TMO) | United States | $151.179B | 18.29 |
| Edwards Lifesciences (EW) | United States | $43.872B | 28.76 |
| Alcon (ALC) | Switzerland | $42.488B | 28.71 |
| IDEXX Laboratories (IDXX) | United States | $40.599B | 46.66 |
| DexCom (DXCM) | United States | $33.262B | 51.41 |
| STERIS (STE) | Ireland | $23.954B | 26.41 |
| IQVIA Holdings (IQV) | United States | $23.881B | 13.38 |
| Mettler-Toledo (MTD) | United States | $23.609B | 28.08 |
| Waters (WAT) | United States | $20.737B | 29.26 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.307B | 0.00 |
| Hologic (HOLX) | United States | $12.141B | 13.19 |
| Sysmex ADR (SSMXY) | Japan | $10.575B | 30.00 |
| Penumbra (PEN) | United States | $10.330B | 81.08 |
| Masimo (MASI) | United States | $8.128B | 29.98 |
| Globus Medical (GMED) | United States | $7.933B | 18.90 |
| Glaukos (GKOS) | United States | $5.553B | 0.00 |
| Teleflex (TFX) | United States | $5.344B | 8.82 |
| TransMedics (TMDX) | United States | $4.172B | 90.69 |
| Integer Holdings (ITGR) | United States | $4.123B | 21.60 |
| PROCEPT BioRobotics (PRCT) | United States | $3.194B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.354B | 14.02 |
| Nihon Kohden (NHNKY) | Japan | $2.062B | 23.65 |
| Elekta AB (EKTAY) | Sweden | $1.990B | 17.89 |
| Alphatec Holdings (ATEC) | United States | $1.824B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.375B | 0.00 |
| Artivion (AORT) | United States | $1.215B | 113.84 |
| Pulse Biosciences (PLSE) | United States | $1.134B | 0.00 |
| OPKO Health (OPK) | United States | $1.007B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.984B | 5.23 |
| SiBone (SIBN) | United States | $0.785B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.672B | 0.00 |
| IRadimed (IRMD) | United States | $0.665B | 33.73 |
| RxSight (RXST) | United States | $0.646B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.603B | 13.19 |
| NeuroPace (NPCE) | United States | $0.586B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.577B | 8.98 |
| Delcath Systems (DCTH) | United States | $0.562B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.514B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.501B | 13.33 |
| AxoGen (AXGN) | United States | $0.498B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.438B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.384B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.382B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.338B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.283B | 0.00 |
| Neuronetics (STIM) | United States | $0.263B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.228B | 13.82 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| Inogen (INGN) | United States | $0.181B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| CVRx (CVRX) | United States | $0.173B | 0.00 |
| 908 Devices (MASS) | United States | $0.170B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.170B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Accuray (ARAY) | United States | $0.163B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.144B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.138B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.126B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.116B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.116B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.112B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.093B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.077B | 46.80 |
| InspireMD (NSPR) | Israel | $0.070B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.060B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.054B | 16.45 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Hyperfine (HYPR) | United States | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.041B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.033B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.75 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |